Miller JS - Search Results

1

Use of natural killer cells as immunotherapy for leukaemia.

Grzywacz B, Miller JS, Verneris MR. Grzywacz B, et al. Among authors: miller js. Best Pract Res Clin Haematol. 2008 Sep;21(3):467-83. doi: 10.1016/j.beha.2008.07.008. Best Pract Res Clin Haematol. 2008. PMID: 18790450 Free PMC article.

2

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1992 Nov 1;80(9):2182-7. Blood. 1992. PMID: 1384796 Free article.

3

Role of monocytes in the expansion of human activated natural killer cells.

Miller JS, Oelkers S, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1992 Nov 1;80(9):2221-9. Blood. 1992. PMID: 1421393 Free article.

4

Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.

Miller JS, Klingsporn S, Lund J, Perry EH, Verfaillie C, McGlave P. Miller JS, et al. Bone Marrow Transplant. 1994 Oct;14(4):555-62. Bone Marrow Transplant. 1994. PMID: 7532064

5

Expansion and activation of human natural killer cells as therapy for autologous transplantation.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. Prog Clin Biol Res. 1994;389:39-45. Prog Clin Biol Res. 1994. PMID: 7700914 No abstract available.

6

Expansion and activation of human natural killer cells for autologous therapy.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. J Hematother. 1994 Spring;3(1):71-4. doi: 10.1089/scd.1.1994.3.71. J Hematother. 1994. PMID: 7922011 Review.

7

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.

Cervantes F, Pierson BA, McGlave PB, Verfaillie CM, Miller JS. Cervantes F, et al. Among authors: miller js. Blood. 1996 Mar 15;87(6):2476-85. Blood. 1996. PMID: 8630414 Free article.

8

Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.

Pierson BA, Europa AF, Hu WS, Miller JS. Pierson BA, et al. Among authors: miller js. J Hematother. 1996 Oct;5(5):475-83. doi: 10.1089/scd.1.1996.5.475. J Hematother. 1996. PMID: 8938519

9

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ. Miller JS, et al. Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44. Biol Blood Marrow Transplant. 1997. PMID: 9209739 Clinical Trial.

10

Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections.

Miller JS, Prosper F, McCullar V. Miller JS, et al. Blood. 1997 Oct 15;90(8):3098-105. Blood. 1997. PMID: 9376591 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,143 results

Search Page

Filters